Axsome Therapeutics earnings were -$287.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest AXSM earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$74.9M, up 16% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AXSM reported annual earnings of -$287.2M, with 20.1% growth. The next AXSM earnings date is May 5, 2025.
Axsome Therapeutics Earnings Reports & History FAQ
What were Axsome Therapeutics's earnings last quarter?
On AXSM's earnings call on Invalid Date, Axsome Therapeutics (NASDAQ: AXSM) reported Q4 2024 earnings per share (EPS) of -$1.54, up 27.7% year over year. Total AXSM earnings for the quarter were -$74.91 million. In the same quarter last year, Axsome Therapeutics's earnings per share (EPS) was -$2.13.
The next AXSM earnings call is Invalid Date. Add AXSM to your watchlist to be reminded of Axsome Therapeutics's next earnings date.
Is Axsome Therapeutics profitable or losing money?
As of the last Axsome Therapeutics earnings report, Axsome Therapeutics is currently losing money. Axsome Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$287.22 million, a 20.05% increase year over year.
What was AXSM's earnings growth in the past year?
As of Axsome Therapeutics's earnings date in Invalid Date, Axsome Therapeutics's earnings has grown year over year. AXSM earnings in the past year totalled -$287.22 million.
What are Axsome Therapeutics's earnings expectations?
The current EPS estimate for Axsome Therapeutics's earnings report in Invalid Date is -$1.21.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.